EUVIMEDOpdag EUVIMED
Crossref

Recent applications of CRISPR-Cas systems in animal models of human cardiovascular disease: Review article

Joshua Longmire, Harrison Smith-Jaoudi, Eesha Balar, Hannah Romeo

Georgetown Medical Review · 2026-08-21 · 10 (1)

DOI: 10.52504/001c.166340 ↗

At a glance

Journal article in Georgetown Medical Review, published online on 2026-08-21. Written by Joshua Longmire and 3 co-authors. 25 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cardiovascular disease (CVD) causes more deaths, more years of life lost, and more years lived with disability than any other major category of disease worldwide. Gene editing technologies, including the CRISPR-Cas9 system and its offshoots, are increasingly applied in CVD animal research models to identify genetic drivers of disease processes and to develop and test targeted therapeutics. To explore the potential impact and limitations of using animal models for these applications, this review examines studies in which the creation of a CRISPR-Cas9 animal model has been used to find genetic drivers and develop therapies. Studies were identified using OVID Medline, searching the past 10 years of the primary literature across 4 CVD domains: congenital heart disease, hypertrophic cardiomyopathy, heart failure, and atherosclerosis. The studies illustrate the vast range of gene editing applications and the value of models that parallel human genetic pathophysiology for specific disease processes. Besides furthering anatomical, clinical, and natural historical understanding of CVD pathologies and providing biological substrates in the development of screening and diagnostic tools, animal models support foundational stages in the development of genetic therapeutics, from gene target identification to discovery and development of gene-editing therapy mechanisms and delivery vehicles, through conducting therapeutic trials to assess the risk-benefit ratio.

Cite

APA

Longmire, J., Smith-Jaoudi, H., Balar, E., & Romeo, H. (2026). Recent applications of CRISPR-Cas systems in animal models of human cardiovascular disease: Review article. Georgetown Medical Review, 10(1). https://doi.org/10.52504/001c.166340

Vancouver

Longmire J, Smith-Jaoudi H, Balar E, Romeo H. Recent applications of CRISPR-Cas systems in animal models of human cardiovascular disease: Review article. Georgetown Medical Review. 2026;10(1). doi:10.52504/001c.166340

BibTeX
@article{Longmire2026,
  author = {Longmire, Joshua and Smith-Jaoudi, Harrison and Balar, Eesha and Romeo, Hannah},
  title = {Recent applications of CRISPR-Cas systems in animal models of human cardiovascular disease: Review article},
  journal = {Georgetown Medical Review},
  year = {2026},
  volume = {10},
  number = {1},
  doi = {10.52504/001c.166340}
}
Start for free →